Anacor Pharmaceuticals Announces Award of $100M in Arbitration with Valeant
October 17, 2013 at 23:29 PM EDT
Anacor Pharmaceuticals (NASDAQ: ANAC ) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (NYSE: VRX ), successor in interest to Dow Pharmaceutical Sciences, Inc.
